España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
SPDR S&P Pharmaceuticals ETF
XPH
ARCA
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for SPDR S&P Pharmaceuticals ETF (ARCA:XPH)
SPDR S&P Pharmaceuticals ETF (ARCA: XPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, August 14, 2024
Pharma ETFs in Focus Post Solid Q2 Earnings
Zacks
Thursday, June 27, 2024
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
Vandana Singh
Thursday, May 09, 2024
A Look at Pharma ETFs Post Q1 Earnings
Zacks
Thursday, May 02, 2024
Organon Beats On Q1, Women's Health Leads the Charge
Lekha Gupta
Sunday, April 30, 2023
Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April
Piero Cingari
Wednesday, November 02, 2022
Chevron, Uber Technologies, And A Way To 'Bet Against The Big Guys' Are CNBC's 'Final Trades'
Priya Nigam
Thursday, April 15, 2021
3 Pharmaceutical ETFs That Could Be Due For A Rebound
Mark Putrino
Sunday, November 15, 2020
Big Pharma In Canada Offers C$1B In Last Attempt To Stop Drug Pricing Crackdown
Catherine Ross
Wednesday, September 25, 2019
'Fast Money Halftime Report' Picks For September 25
Craig Jones
Monday, May 06, 2019
From Sohn Conference: Larry Robbins Recommend...
Benzinga Newsdesk
Thursday, August 02, 2018
These 5 Sector ETFs Were Among The Best Performers In July
Zacks
Thursday, June 28, 2018
Amazon Breaks Walgreens' Bullish Cycle, More Downside To Come
Benzinga
Thursday, November 09, 2017
Pharma ETFs Down Post Q3 Earnings
Benzinga
Monday, July 10, 2017
What Lies Ahead For Pharma ETFs In Second Half 2017
Benzinga
Thursday, December 08, 2016
Biotech Stocks Convalescing After Wednesday's Trump-Inspired Biotech Selloff
Benzinga
Wednesday, November 09, 2016
Last Night's Election - A Series Of Fortunate Events For Big Pharma
Benzinga
Tuesday, September 27, 2016
Getting Into The Drug Business: From NDAs To PDUFA Dates
Benzinga
Thursday, June 02, 2016
Morgan Stanley: How Much Would Pharma Companies Lose If The Whole Country Got VA Drug Prices?
Benzinga
Tuesday, July 28, 2015
ETFs For The Next Pharma Takeover Candidates
Benzinga
Wednesday, September 17, 2014
Is Akorn, Inc. An Easy Buy This Week?
Benzinga
Friday, April 25, 2014
3 Ways To Profit From Merger Activity In The Pharmaceutical Sector
Benzinga
Tuesday, April 22, 2014
Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)
Benzinga
Friday, April 04, 2014
A Tale of Two Headlines
Benzinga
Wednesday, October 02, 2013
Pharmaceutical Industry Expected To Collect Billions From Obamacare
Benzinga
Friday, August 02, 2013
S&P: Heaping Praise For Some Health Care ETFs
Benzinga
Tuesday, June 18, 2013
Interesting Similarities Among 2013's Top-Performing ETFs
Benzinga
Thursday, February 28, 2013
If The Market Falls, Try These Low Beta ETFs
Benzinga
Friday, November 16, 2012
S&P Reiterates Bullish View on Health Care ETFs
Benzinga
Tuesday, October 09, 2012
These ETFs Have Stellar Dividend Growth
Benzinga
Tuesday, June 19, 2012
Top 10 Healthcare ETFs
Benzinga
Thursday, April 19, 2012
S&P: Bullish On Pharma ETFs Long-Term
Benzinga
Thursday, February 23, 2012
Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)
Benzinga
Friday, January 06, 2012
Can This Pharmaceutical Company Make You Rich?
Benzinga
Friday, December 30, 2011
ETF Showdown: Fun With Pharma
Benzinga
Monday, October 31, 2011
A Look at The New DRGS ETN
Benzinga
Thursday, July 21, 2011
Fifteen Health Care ETFs Trading Near 52-Week Highs
Benzinga
Wednesday, July 13, 2011
Twelve Health Care ETFs Trading Near 52-Week Highs
Benzinga
Sunday, January 30, 2011
3 New SPDR Equal-Weighted Industry ETFs
Benzinga
Tuesday, October 12, 2010
Benzinga's Top ETF Gainers (SGG, DAG, XPH, FAS)
Benzinga
Alchemy Real-Time Stream From Monday, 10/11/10
Benzinga
Wednesday, June 30, 2010
Pharmaceutical ETFs on the Rise
Benzinga
Thursday, February 18, 2010
Benzinga's Top ETF Decliners (DTO, XPH, SCO, UNG)
Benzinga
Friday, December 11, 2009
Eli Lilly (LLY) Is Facing Big Challenges
Benzinga
